Stocks & Investing
Mon, September 23, 2024
[ Mon, Sep 23rd 2024
] - WOPRAI
Tue, August 27, 2024
[ Tue, Aug 27th 2024
] - WOPRAI
Mon, August 19, 2024
[ Mon, Aug 19th 2024
] - WOPRAI
Wed, July 3, 2024
[ Wed, Jul 03rd 2024
] - WOPRAI
Fri, June 7, 2024
[ Fri, Jun 07th 2024
] - WOPRAI
Thu, April 25, 2024
[ Thu, Apr 25th 2024
] - WOPRAI
Mon, April 22, 2024
[ Mon, Apr 22nd 2024
] - WOPRAI
Fri, April 5, 2024
[ Fri, Apr 05th 2024
] - WOPRAI
Mon, February 12, 2024
[ Mon, Feb 12th 2024
] - WOPRAI
Fri, December 15, 2023
[ Fri, Dec 15th 2023
] - WOPRAI
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
Fri, July 14, 2023
[ Fri, Jul 14th 2023
] - WOPRAI
Mon, June 26, 2023
[ Mon, Jun 26th 2023
] - WOPRAI
Tue, March 28, 2023
[ Tue, Mar 28th 2023
] - WOPRAI
Mon, December 12, 2022
[ Mon, Dec 12th 2022
] - WOPRAI
Wed, December 7, 2022
[ Wed, Dec 07th 2022
] - WOPRAI
Thu, March 10, 2022
[ Thu, Mar 10th 2022
] - WOPRAI
Wed, September 8, 2021
[ Wed, Sep 08th 2021
] - WOPRAI
Tue, May 11, 2021
[ Tue, May 11th 2021
] - WOPRAI
Mon, April 26, 2021
[ Mon, Apr 26th 2021
] - WOPRAI
Mon, March 1, 2021
[ Mon, Mar 01st 2021
] - WOPRAI
Joseph Catanzaro Maintained (BDTX) at Buy with Increased Target to $15 on, Sep 23rd, 2024
Joseph Catanzaro of Piper Sandler, Maintained "Black Diamond Therapeutics, Inc." (BDTX) at Buy with Increased Target from $12 to $15 on, Sep 23rd, 2024.
Joseph has made no other calls on BDTX in the last 4 months.
There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Wednesday, September 18th, 2024
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $16 on, Tuesday, September 10th, 2024
- Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024
